HIV Prevention Trials Network Launches HPTN 094 (INTEGRA) Study
June 09, 2021 10:20 ET | HIV Prevention Trials Network (HPTN)
Durham, N.C., June 09, 2021 (GLOBE NEWSWIRE) -- The HIV Prevention Trials Network (HPTN) announced today the launch of HPTN 094 (INTEGRA), a study to determine whether using mobile health units to...
image.png
HIV Prevention Trials Network Awarded U.S. National Institutes of Health Funding to Continue Research Agenda
November 30, 2020 22:32 ET | HIV Prevention Trials Network (HPTN)
DURHAM, N.C., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Drs. Myron S. Cohen and Wafaa M. El-Sadr, principal investigators of the HIV Prevention Trials Network (HPTN), in collaboration with FHI 360, have...
Long-Acting Injectable Cabotegravir Is Highly Effective for the Prevention of HIV Infection in Cisgender Men and Transgender Women Who Have Sex With Men
May 18, 2020 06:37 ET | HIV Prevention Trials Network (HPTN)
DURHAM, N.C., May 18, 2020 (GLOBE NEWSWIRE) -- The HIV Prevention Trials Network (HPTN) announced today results from HPTN 083, a global randomized, controlled, double-blind study that compared the...